Diagnamed Holdings Corp.
Diagnamed Holdings Corp. engages in the development and commercialization of AI healthcare solutions. The company focuses on developing BRAIN AGE BRAIN HEALTH, a brain health AI platform leveraging that aims to predict and monitor brain age and provide actionable insights for mental health and neurodegenerative disorders. It has a collaboration agreement with EIREX for the development and commerc… Read more
Diagnamed Holdings Corp. (DGNMF) - Net Assets
Latest net assets as of September 2025: $-450.11K USD
Based on the latest financial reports, Diagnamed Holdings Corp. (DGNMF) has net assets worth $-450.11K USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($216.36K) and total liabilities ($666.47K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-450.11K |
| % of Total Assets | -208.04% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 72.14 |
Diagnamed Holdings Corp. - Net Assets Trend (2021–2025)
This chart illustrates how Diagnamed Holdings Corp.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Diagnamed Holdings Corp. (2021–2025)
The table below shows the annual net assets of Diagnamed Holdings Corp. from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $-450.11K | -69.75% |
| 2024-09-30 | $-265.17K | -212.41% |
| 2023-09-30 | $235.89K | -81.07% |
| 2022-09-30 | $1.25 Million | -44.37% |
| 2021-09-30 | $2.24 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Diagnamed Holdings Corp.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 431457100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $5.81 Million | % |
| Total Equity | $-450.11K | 100.00% |
Diagnamed Holdings Corp. Competitors by Market Cap
The table below lists competitors of Diagnamed Holdings Corp. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sirisoft Public Company Limited
BK:SRS
|
$1.63 Million |
|
Kula Gold Ltd
AU:KGD
|
$1.63 Million |
|
Sirona Biochem Corp
PINK:SRBCF
|
$1.63 Million |
|
Inca Minerals Ltd
AU:ICG
|
$1.64 Million |
|
Aspire BioPharma, Inc.
NASDAQ:ASBP
|
$1.63 Million |
|
ARCUS DEVELOPMENT
MU:AJR
|
$1.63 Million |
|
Exemplar REITail Ltd
JSE:EXP
|
$1.63 Million |
|
RENEURON GRP PLC LS-01
F:RQE1
|
$1.63 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Diagnamed Holdings Corp.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -265,167 to -450,111, a change of -184,944.
- Net loss of 1,403,145 reduced equity.
- Other factors increased equity by 1,218,201.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.40 Million | -311.73% |
| Other Changes | $1.22 Million | +270.64% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Diagnamed Holdings Corp.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-09-30 | $0.03 | $0.02 | x |
| 2022-09-30 | $0.02 | $0.02 | x |
| 2023-09-30 | $0.00 | $0.02 | x |
| 2024-09-30 | $0.00 | $0.02 | x |
| 2025-09-30 | $0.00 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Diagnamed Holdings Corp. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-143.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -86.97% | 0.00% | 0.00x | 1.07x | $-2.17 Million |
| 2022 | -90.88% | 0.00% | 0.00x | 1.30x | $-1.26 Million |
| 2023 | -541.75% | 0.00% | 0.00x | 2.81x | $-1.30 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-474.54K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.36 Million |
Industry Comparison
This section compares Diagnamed Holdings Corp.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $171,670,176
- Average return on equity (ROE) among peers: -102.33%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Diagnamed Holdings Corp. (DGNMF) | $-450.11K | -86.97% | N/A | $1.63 Million |
| Accolade, Inc. (ACCD) | $390.85 Million | -12.96% | 0.22x | $448.32 Million |
| Achiko AG (ACHKF) | $-625.49K | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $71.10 Million | 9.14% | 1.86x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-6.40 Million | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $970.06K | -720.88% | 1.19x | $1.93 Million |
| Alternate Health Corp (AHGIF) | $-13.82K | 0.00% | 0.00x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $-1.77 Million | 0.00% | 0.00x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $1.83 Million | -284.61% | 0.19x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-118.08K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $1.26 Billion | -13.99% | 0.15x | $78.48 Million |